Cargando…
A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors
Significant advances in gene therapy have enabled exploration of therapies for inherited retinal disorders, many of which are in preclinical development or clinical evaluation. Gene therapy for retinal conditions has led the way in this growing field. The loss of retinal ganglion cells (RGCs) is a h...
Autores principales: | Hanlon, Killian S., Chadderton, Naomi, Palfi, Arpad, Blanco Fernandez, Alfonso, Humphries, Peter, Kenna, Paul F., Millington-Ward, Sophia, Farrar, G. Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613148/ https://www.ncbi.nlm.nih.gov/pubmed/28983234 http://dx.doi.org/10.3389/fnins.2017.00521 |
Ejemplares similares
-
Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells
por: Millington-Ward, Sophia, et al.
Publicado: (2020) -
AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice
por: Palfi, Arpad, et al.
Publicado: (2022) -
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction
por: Chadderton, Naomi, et al.
Publicado: (2023) -
AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1−/− Retinas
por: Palfi, Arpad, et al.
Publicado: (2020) -
SARM1 Ablation Is Protective and Preserves Spatial Vision in an In Vivo Mouse Model of Retinal Ganglion Cell Degeneration
por: Finnegan, Laura K., et al.
Publicado: (2022)